Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Raymond

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|May 13, 2024
Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational studyWing Ming Chu, Eric Yuk Fai Wan, Zoey Cho Ting Wong, et al.
The Lancet. Infectious Diseases|July 18, 2024
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation studyMing Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, et al.
The Clinical Respiratory Journal|March 27, 2025
Implication of Admission Eosinophil Count and Prognosis of Coronavirus Disease 2019 (COVID-19) in Elderly Patients With COPD: A Territory-Wide Cohort StudyWang Chun Kwok, Yat Fung Shea, James Chung Man Ho, et al.
Nephrology (Carlton, Vic.)|September 20, 2020
Case of "relapsing" COVID-19 in a kidney transplant recipientBecky Mingyao Ma, Ivan Fan Ngai Hung, Gary Chi Wang Chan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 5, 2025
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and molnupiravir versus monotherapy with molnupiravir or nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A target trial emulation studyEric Yuk Fai Wan, Ming Hong Choi, Boyuan Wang, et al.
The Clinical Respiratory Journal|February 11, 2022
Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19)Wang Chun Kwok, Anthony Raymond Tam, James Chung Man Ho, et al.
Heliyon|August 21, 2024
The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipientsHoi-Wah Tsoi, Miko Ka-Wai Ng, Jian-Piao Cai, et al.
Frontiers in Immunology|October 28, 2022
Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccinesChi-Ho Lee, Victor Gray, Jia Ming Nickolas Teo, et al.
Healthcare (Basel, Switzerland)|April 12, 2025
Generative Artificial Intelligence Models in Clinical Infectious Disease Consultations: A Cross-Sectional Analysis Among Specialists and Resident TraineesEdwin Kwan-Yeung Chiu, Siddharth Sridhar, Samson Sai-Yin Wong, et al.
Genome Biology and Evolution|December 10, 2015
Organellar Genomes of White Spruce (Picea glauca): Assembly and AnnotationShaun D Jackman, René L Warren, Ewan A Gibb, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|May 13, 2024
Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational studyWing Ming Chu, Eric Yuk Fai Wan, Zoey Cho Ting Wong, et al.
The Lancet. Infectious Diseases|July 18, 2024
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation studyMing Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, et al.
The Clinical Respiratory Journal|March 27, 2025
Implication of Admission Eosinophil Count and Prognosis of Coronavirus Disease 2019 (COVID-19) in Elderly Patients With COPD: A Territory-Wide Cohort StudyWang Chun Kwok, Yat Fung Shea, James Chung Man Ho, et al.
Nephrology (Carlton, Vic.)|September 20, 2020
Case of "relapsing" COVID-19 in a kidney transplant recipientBecky Mingyao Ma, Ivan Fan Ngai Hung, Gary Chi Wang Chan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 5, 2025
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and molnupiravir versus monotherapy with molnupiravir or nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A target trial emulation studyEric Yuk Fai Wan, Ming Hong Choi, Boyuan Wang, et al.
The Clinical Respiratory Journal|February 11, 2022
Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19)Wang Chun Kwok, Anthony Raymond Tam, James Chung Man Ho, et al.
Heliyon|August 21, 2024
The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipientsHoi-Wah Tsoi, Miko Ka-Wai Ng, Jian-Piao Cai, et al.
Frontiers in Immunology|October 28, 2022
Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccinesChi-Ho Lee, Victor Gray, Jia Ming Nickolas Teo, et al.
Healthcare (Basel, Switzerland)|April 12, 2025
Generative Artificial Intelligence Models in Clinical Infectious Disease Consultations: A Cross-Sectional Analysis Among Specialists and Resident TraineesEdwin Kwan-Yeung Chiu, Siddharth Sridhar, Samson Sai-Yin Wong, et al.
Genome Biology and Evolution|December 10, 2015
Organellar Genomes of White Spruce (Picea glauca): Assembly and AnnotationShaun D Jackman, René L Warren, Ewan A Gibb, et al.
Pageof 8